Filing Details
- Accession Number:
- 0001140361-12-051346
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-12-14 18:17:00
- Reporting Period:
- 2012-12-05
- Filing Date:
- 2012-12-14
- Accepted Time:
- 2012-12-14 18:17:00
- Original Submission Date:
- 2012-12-10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033150 | N John Kapoor | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-12-05 | 75,000 | $12.71 | 26,233,979 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2012-12-05 | 328,283 | $12.71 | 25,905,696 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2012-12-05 | 185,540 | $12.71 | 25,720,156 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2012-12-05 | 185,540 | $12.71 | 25,534,616 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2012-12-05 | 372,531 | $12.71 | 25,162,085 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2012-12-05 | 853,106 | $12.71 | 24,308,979 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- Securities held through various limited partnerships and trusts. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his pecuniary interest.
- Dr. Kapoor, on his own behalf and on behalf of several trusts of which he is a trustee, has terminated all previously announced Rule 10b5-1 trading plans covering 4,000,000 shares of Akorn stock. No sales of securities were consummated under the terminated trading plans.
- The original Form 4 inadvertently disclosed incorrect transaction codes. This amendment reflects the correct transaction code for each transaction, which stands for the open market or private sale of non-derivative or derivative security. No other amendments are being made to the original Form 4.
Billionaire Hedge Funds
